Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Anika Therapeutics Inc (NASDAQ:ANIK)

47.35
Delayed Data
As of Jul 24
 -0.56 / -1.17%
Today’s Change
41.38
Today|||52-Week Range
53.50
-3.29%
Year-to-Date

Today’s Trading

Previous close47.91
Today’s open47.67
Day’s range47.23 - 47.84
Volume67,739
Average volume (3 months)107,439
Market cap$702.1M
Dividend yield--
Data as of 07/24/2017

Growth & Valuation

Earnings growth (last year)+6.97%
Earnings growth (this year)-11.01%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+11.16%
P/E ratio22.9
Price/Sales7.16
Price/Book3.15

Competitors

 Today’s
change
Today’s
% change
GNMKGenMark Diagnostics ...+0.04+0.33%
CRYCryoLife Inc+0.55+2.87%
XENTIntersect ENT Inc+0.70+2.51%
ATRCAtriCure Inc-0.16-0.67%
Data as of 07/24/2017

Financials

Next reporting dateJuly 27, 2017
EPS forecast (this quarter)$0.44
Annual revenue (last year)$103.4M
Annual profit (last year)$32.5M
Net profit margin31.48%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Charles H. Sherwood
Chief Operating Officer
Dana M. Alexander
Corporate headquarters
Bedford, Massachusetts

Forecasts